Skip to main content

Advertisement

ADVERTISEMENT

Volume 34 - Issue 5 - May, 2022

05/01/2022
May 2022 Table of Contents and Whole Issue PDF
May 2022 Table of Contents and Whole Issue PDF
May 2022 Table of Contents and...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
05/01/2022

Ashwat S. Dhillon, MD; Brandon M. Jones, MD; Robert W. Hodson, MD; Ethan C. Korngold, MD

Ashwat S. Dhillon, MD; Brandon M. Jon...
There are limited invasive treatment options for patients with end-stage heart failure and left ventricular assist device (LVAD) who develop severe aortic valve regurgitation (AR). One option for such patients is transcatheter aortic valve...
There are limited invasive treatment options for patients with end-stage heart failure and left ventricular assist device (LVAD) who develop severe aortic valve regurgitation (AR). One option for such patients is transcatheter aortic valve...
There are limited invasive...
05/01/2022
Journal of Invasive Cardiology

Feature

Original Contribution
05/01/2022

Christina Paitazoglou, MD1,2; Martin W. Bergmann, MD, PhD1,3; Hüseyin Ince, MD4;  Stephan Kische, MD5; Aleksandr Romanov, MD6; Thomas Schmitz, MD7; Boris Schmidt, MD8; Tommaso Gori, MD9; Felix Meincke, MD10; Alexey Vladimir Protopopov, MD, PhD11; Timothy Betts, MD12; Elisa Vireca13;  Peter Wohlmuth14; Lucas Boersma, MD, PhD15; on behalf of the EWOLUTION Investigators

Christina Paitazoglou, MD1,2; Martin ...
Left atrial appendage occlusion (LAAO) is recommended for patients with atrial fibrillation at increased stroke risk, where effective long-term oral anticoagulation (OAC) is not feasible. In order to assess long-term safety of LAAO with...
Left atrial appendage occlusion (LAAO) is recommended for patients with atrial fibrillation at increased stroke risk, where effective long-term oral anticoagulation (OAC) is not feasible. In order to assess long-term safety of LAAO with...
Left atrial appendage occlusion...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
05/01/2022

Salman Farhat, MBBS1; Abdallah El Sabbagh, MD1; Mohammed Al-Hijji, MD2; Keniel Pierre, MD1;  Nahyr S. Lugo-Fagundo, MD1; Yader Sandoval, MD2; Michael S. Gharacholou, MD1; Peter M. Pollak, MD1; Mandeep Singh, MD2; Mackram F. Eleid, MD2; Mohammed Al-Khouli, MD2; David R. Holmes, MD2; Mayra Guerrero, MD2; Rajiv Gulati, MD2; Malcolm Bell, MD2; Charanjit S. Rihal, MD2

Salman Farhat, MBBS1; Abdallah El Sab...
This study included consecutive patients who underwent PCI within 30 days before TAVR at Mayo Clinic. Vascular access was left to the discretion of the operator. Baseline demographics, procedural data, PCI outcomes, and subsequent...
This study included consecutive patients who underwent PCI within 30 days before TAVR at Mayo Clinic. Vascular access was left to the discretion of the operator. Baseline demographics, procedural data, PCI outcomes, and subsequent...
This study included consecutive...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
05/01/2022

Janusz Lipiecki, MD1; Rajiv Rampat, MD2; Christophe Piot, MD3; Hakim Benamer, MD4; François Brunelle, MD5; Thierry Lefèvre, MD4; Rami el Mahmoud, MD6; Olivier Varenne, MD7; Antoine Gommeaux, MD8; Vincent Malquarti, MD; Denis Angoulvant, MD10; Clauset Cruchon, MD11; Keith Oldroyd, MD11; Christian Spaulding, MD12

Janusz Lipiecki, MD1; Rajiv Rampat, M...
Dual-antiplatelet treatment (DAPT) has conventionally been prescribed for 1 year after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation. Recent evidence suggests that a duration of only 6 months may be...
Dual-antiplatelet treatment (DAPT) has conventionally been prescribed for 1 year after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation. Recent evidence suggests that a duration of only 6 months may be...
Dual-antiplatelet treatment...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
05/01/2022

William R. Miranda, MD1; Donald J. Hagler, MD2; Heidi M. Connolly, MD1; Patrick S. Kamath, MD3; Alexander C. Egbe, MBBS, MPH1

William R. Miranda, MD1; Donald J. Ha...
The correlation between hemodynamics and clinical phenotypes/symptoms in adults post Fontan procedure has not been well studied. Moreover, the “expected” hemodynamics in those who are asymptomatic remain unclear.
The correlation between hemodynamics and clinical phenotypes/symptoms in adults post Fontan procedure has not been well studied. Moreover, the “expected” hemodynamics in those who are asymptomatic remain unclear.
The correlation between...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
05/01/2022

Jonathan A. Mailey, MBChB, FRCP; Paul F. Brennan, MD, FRCP; Aileen Kearney, MBChB, FRCP; Meadhbh C. Hogg, MBChB; Andrew H. McNeice, MBChB, FRCP; Reuben Jeganathan, MD, FRCS; Ganesh Manoharan, MD, FRCP; Colum G. Owens, MD, FRCP; Mark S. Spence, MD, FRCP

Jonathan A. Mailey, MBChB, FRCP; Paul...
This was an observational study of 279 patients treated with the Sapien 3 THV. Fluoroscopic imaging was used to categorize patients into low (n = 147), intermediate (n = 86), and high (n = 46) implantation zones. These zones were based on the...
This was an observational study of 279 patients treated with the Sapien 3 THV. Fluoroscopic imaging was used to categorize patients into low (n = 147), intermediate (n = 86), and high (n = 46) implantation zones. These zones were based on the...
This was an observational study...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
05/01/2022

Konrad A.J. van Beek, BSc1,2; Anouk G.W. de Lepper, MD1; Marcel van’t Veer, PhD1; Sjoerd Bouwmeester, MD1; Luuk C. Otterspoor, MD, PhD1; Pim A.L. Tonino, MD, PhD1; Jeroen Lammers, MD3; Mark Winkens, MD, PhD4; Lokien X. van Nunen, MD, PhD1

Konrad A.J. van Beek, BSc1,2; Anouk G...
It is unknown whether computed tomographic coronary angiography (CTCA) can be used to perform ultraselective invasive coronary angiography (ICA) by only visualizing the abnormal coronary artery on CTCA and defer visualization of the normal...
It is unknown whether computed tomographic coronary angiography (CTCA) can be used to perform ultraselective invasive coronary angiography (ICA) by only visualizing the abnormal coronary artery on CTCA and defer visualization of the normal...
It is unknown whether computed...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
05/01/2022

Patricia Ying Jia Ding, MB ChB1,4; Sudhakar George, MD2; John A. Ormiston, MB ChB3; Bruce Webber, BSc(Hon)3; Eliazar Dimalapang1; Mark Webster, MD1

Patricia Ying Jia Ding, MB ChB1,4; Su...
Percutaneous coronary intervention with Y-stenting of coronary bifurcation disease is not commonly undertaken. The procedural and medium-term clinical outcomes of coronary bifurcation lesions treated with the proximal to distal Y stent...
Percutaneous coronary intervention with Y-stenting of coronary bifurcation disease is not commonly undertaken. The procedural and medium-term clinical outcomes of coronary bifurcation lesions treated with the proximal to distal Y stent...
Percutaneous coronary...
05/01/2022
Journal of Invasive Cardiology
Brief Communication
05/01/2022

Steffne Kunnirickal, MD1; Steven Pfau, MD1,2,3; Edward Moran, RTR3; Samit Shah, MD, PhD1,2,3

Steffne Kunnirickal, MD1; Steven Pfau...
We describe a novel catheter, the MOT-C (Merit Medical Systems), for selective diagnostic angiography of the internal mammary artery from radial access.
We describe a novel catheter, the MOT-C (Merit Medical Systems), for selective diagnostic angiography of the internal mammary artery from radial access.
We describe a novel catheter,...
05/01/2022
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement